|
CNBC'S MOST SHARED
- Investing in Tech Now
- Apartment Vacancy Rate Hits 22-Year High
- Warren Buffett's Complete Sun Valley CNBC Interview - Transcript and Video
- Warren Buffett Tells CNBC Consumer Sales Remain "Very, Very Soft"
- What You'll See On My NASCAR Documentary Tonight
- Warren Buffett: Economy Needs Another Dose of Viagra
- Software Giants Rush to Cash In on Carbon-Trading
- Preparing for Retirement
- Cramer?s Outrage
- Man in the Middle of it All
- Warren Buffett's Complete Sun Valley CNBC Interview - Transcript and Video
- Warren Buffett Tells CNBC Consumer Sales Remain "Very, Very Soft"
- July 10th in Market History
- Microsoft Plays a Game of Bing Pong
- Options Smell 'Blood' on Infosys
- Christmas in July: Consumers To Out-Scrooge Scrooge
- GM's Second Chance
- Art Cashin: Traders Weigh Obama Policy Changes
- Warren Buffett: Economy Needs Another Dose of Viagra
- China Demands Currency Reform, France Backs Debate
- China Accuses Rio Staff of Bribing Steelmakers
- Assets Are Less Toxic, but Banks Have Other Troubles
- Chevron Says Q2 Hit by US Refining, Weak Dollar
- Stimulus Critics Put Obama, Democrats on Defensive
- Warren Buffett: Consumer Sales Remain 'Very, Very Soft'
- Japan Deflation Deepens as Wholesale Prices Tumble
- Infosys First-Quarter Profit Rises 17%, Beats Estimates
- Google CEO Sees Chrome Netbook News Later This Year
RSS FEED

![]() |
The study, paid for by Clialis-maker Eli Lilly [LLY
Loading...
()
], shows nearly 40 percent of men have never broached the subject with their physician, even though 82 percent of men know ED could be a symptom of serious health problems.
You can read all sorts of other fun factoid findings of the survey here. LLY claims it interviewed the 300 men who are at least 45 years old "to further understand men's current beliefs about ED and DE treatment options, as well as the perceptions men have about communicating with their healthcare professional about ED."
Yeah, uh-huh, sure.
I'm guessin' they knew I couldn't resist blogging about ED.
Lilly has turned Cialis--the pill that lasts in your system for a day-and-a-half--into a blockbuster. And it recently launched a one-a-day version of the drug. Pfizer sold nearly half-a-billion dollars worth of Viagra in the first quarter of this year. GlaxoSmithKline [GSK
Loading...
()
], Schering-Plough [SGP
Loading...
()
] and the German Bayer[BAY
Loading...
()
] share Levitra which is an also-ran, me-too ED drug. But I do know one new Levitra convert. A certain co-worker, who will remain unnamed, recently told me he spent more than 300 bucks to fill a Levitra prescription his neighbor wrote for him. Mr. Anonymous said he'd grown frustrated with his primary care physician who would only write him tiny, apparently insufficient, prescriptions for Viagra.
I also wonder what, if any, impact General Motors' [GM
Loading...
()
]decision to cut healthcare benefits for retirees could have on ED drug sales. Especially if other companies follow GM's lead.
We'll get a read on more recent impotence pill sales when big pharma starts reporting earnings next week.
Questions? Comments?



.ll_medium.jpg)




